Previous Close | 47.99 |
Open | 47.41 |
Bid | 0.00 x 800 |
Ask | 0.00 x 900 |
Day's Range | 46.69 - 72.99 |
52 Week Range | 21.65 - 73.02 |
Volume | |
Avg. Volume | 1,803,609 |
Market Cap | 4.114B |
Beta (5Y Monthly) | 0.86 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -4.45 |
Earnings Date | Feb 22, 2022 - Feb 28, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 59.53 |
Acquiring the maker of a recently approved drug for sickle-cell disease would be the latest move by the drug giant to bolster its portfolio and pipeline.
The stock market traded mixed on Friday on hot job numbers, closing out the week with gains. AMC popped on earnings beat.
Rumors that Pfizer is in "advanced talks" to acquire Global Blood Therapeutics for about $5 billion sent GBT stock flying Friday.